1. Role of Medical Imaging in Cancers.
- Author
-
Fanti, Stefano, Evangelista, Laura, and Fanti, Stefano
- Subjects
Medicine ,18F-FACBC ,18F-FDG PET/CT ,68Gallium-PSMA PET/CT ,Adoptive ,CD8-Positive T-Lymphocytes ,CTLA-4 Antigen ,Computer-assisted diagnosis ,DCFBC ,DCFPyL ,Deauville criteria ,EBV ,FDG ,FDG-PET/CT ,HPV ,Hodgkin lymphoma ,Hounsfield unit ,Immunotherapy ,International Consensus Guidelines ,MRI ,Mesothelin ,Molecular imaging ,NSCLC ,PD-1 ,PD-L1 ,PDAC ,PERCIST ,PET ,PET/CT ,PET/MRI ,PI-RADS ,PSA kinetics thresholds ,PSMA ,PSMA-1007 ,Radium-223 ,SPECT imaging ,SPECT/CT ,SUV ,SUVmax ,Therapy response assessment ,VCAM-1 ,XOFIGO ,Yin Yang 1 ,adipose tissue ,biochemical recurrence ,biomarker ,biomarkers ,bladder cancer ,breast ,breast cancer ,castrate resistant prostate cancer ,circulating miRNAs ,circulating tumor cells ,computed tomography ,concurrent chemoradiotherapy ,consensus ,cystic tumor ,diagnosis ,diagnostic imaging ,diffuse large B-cell lymphoma ,diffusion ,diffusion kurtosis imaging ,diffusion tensor imaging ,diffusion-weighted imaging ,dynamic 18F-FDG PET/CT ,dynamic contrast-enhanced magnetic resonance imaging ,empyema ,epistemology ,follow up ,glioblastoma ,gold nanoparticle ,guidelines ,head and neck cancer ,head and neck neoplasms ,heat shock protein 70 ,imaging ,imaging parameters ,immune checkpoint inhibitors ,immunotherapy ,intraductal papillary mucinous neoplasms ,locally advanced cervical cancer ,mCRPC ,machine learning ,magnetic resonance imaging ,malignant pleural mesothelioma ,mantle cell lymphoma ,marker ,meningioma ,meta-analysis ,metastatic breast cancer ,miRNA expression ,molecular imaging ,n/a ,neovascularization ,neuroimaging ,non-small-cell lung cancer ,noninvasive imaging ,nuclear medicine ,optimal cutoff level ,ovarian cancer ,overutilization ,p16 ,pancreatic neoplasms ,pathologic ,pazopanib ,perfusion ,pleural dissemination ,pleural effusion ,positron emission tomography ,positron-emission tomography ,precision oncology ,prognosis ,programmed cell death 1 receptor ,prostate ,prostate cancer ,prostate-specific-antigen ,radiation therapy ,radioactive tracers ,radiogenomics ,radiomic ,radiomics ,radionuclide imaging ,radionuclide therapy ,receptor status ,recurrence ,relapse ,response assessment ,response to therapy ,response to treatment ,review ,sdAbs ,single-photon emission computed tomography ,soft tissue sarcoma (STS) ,somatostatin receptor ,spectral-CT ,squamous cell carcinoma of the head and neck ,staging ,survival ,targeted therapy ,texture analysis ,treatment response ,triple negative breast cancer ,two-tissue compartment model ,upper tract urothelial carcinoma ,urothelial carcinoma - Abstract
Summary: The issue of Cancers Journal entitled "Role of Medical Imaging in Cancers" presents a detailed summary of evidences about molecular imaging, including the role of computed tomography (CT), magnetic resonance imaging (MRI), single photon emission tomography (SPET) and positron emission tomography (PET) or PET/CT or PET/MR imaging in many type of tumors (i.e. sarcoma, prostate, breast and others), motivating the role of these imaging modalities in different setting of disease and showing the recent developments, in terms of radiopharmaceuticals, software and artificial intelligence in this field. The collection of articles is very useful for many specialists, because it has been conceived for a multidisciplinary point of view, in order to drive to a personalized medicine.